Current Drug Safety publishes frontier articles on all the latest advances in drug safety. The journal aims to publish the highest quality research articles, full-length/mini reviews and case reports in the field. Topics covered include adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, and post-marketing surveillance. It also includes articles focused on resources for identification of harmful substances and cellular, biochemical, and molecular mechanisms which are responsible for the side effects of drugs. The journal is an essential reading for all researchers and clinicians involved in drug safety.
Seetal Dodd School of Medicine University of Melbourne Geelong, Melbourne (Australia) Biography
Biography of Seetal Dodd
Dodd obtained a doctorate (Ph.D.) from the University of Melbourne, Australia. He is a Principal Fellow in the Department of Psychiatry, University of Melbourne, a Clinical Associate Professor at the Centre for Youth Mental Health, University of Melbourne, and a Clinical Associate Professor in the School of Medicine, Deakin University, Australia. He has published over 180 scientific publications. A/Prof Dodd is currently Editor-in-Chief of Current Drug Safety, published by Bentham Science Publishers.